Some of the names on the move ahead of the open.» Read More
Check out which companies are making headlines after the bell Wednesday:
CNBC's Melissa Lee and the Fast Money traders discuss the day's top trades and the stocks they'll be watching Thursday.
With 30 percent of the S&P 500 reporting, it's clear there is a trend developing. Revenues are in trouble. But earnings continue to grow.
Alcohol stocks offer some of the most exciting growth right now. TheStreet.com takes a look at five names that are well-positioned to round out your booze portfolio in 2013.
Hedge fund manager John Paulson told investors to expect continued, short-term volatility in gold as well as further consolidation in the telecom business in the wake of a MetroPCS Communications merger with Deutsche Telekom's T-Mobile unit that was approved earlier in the day.
One ignored stock offers double-digit return potential, Bill Nygren says.
Toni Sacconaghi says that Apple still has innovation and growth ahead of it.
Kynikos Associates' Jim Chanos, shares his views on Herbalife and why he believes the multi-level marketing model is flawed, and why he has questions about Netflix.
Bill Nygren, Oakmark Fund, shares his plays on Apple and DirecTV, and explains why he sold his position in Dell. And Jim Chanos, Kynikos Associates, discusses what he looks for before shorting a stock.
The rampant growth of credit in China appears to be forming a bubble, Jim Chanos of Kynikos Associates says.
A leading venture capitalist told CNBC that Apple no longer feels like a "real tech company."
Cramer shares six stocks to watch, and reveals them in under 60 seconds; including Edward Life Sciences, Panera Bread, and Eli Lily.
Earnings: Still choppy, but mostly good news for tech and building materials.
Some of the names on the move ahead of the open.
This is a link to a Bankrate.com story.
Braskem is trading near 52-week highs, and yesterday the option paper was bullish on the Brazilian petrochemical company.
Why did gold crash? Ron Paul points his finger at two potential culprits: The Obama administration and Goldman Sachs.
Amgen's stock fell sharply in after-hours trading after it reported sales that fell short of Wall Street's expectations.
Some investors are starting to wonder if Apple's relatively strong earnings might ignite the next leg higher. Jim Cramer investigates.
Schwab's website was back up after it was incapacitated by what appeared to be a denial-or-service attack.